Prescription opioid use is an initiating factor driving the current opioid epidemic. There are several challenges with modeling prescription opioid addiction. First, prescription opioids such as oxycodone are orally self-administered and have different pharmacokinetics and dynamics than morphine or fentanyl. This oral route of administration determines the pharmacokinetic profile, which is critical for establishing reliable drug-reinforcement associations in animals. Second, intravenous opioid self-administration is typically performed with intermittent drug self-administration sessions in a separate environment from the home cage. This does not recapitulate prescription opioid use, which is characterized by continuous drug access in the patients homes. To model features of prescription opioid use and the transition to abuse, we developed an oxycodone self-administration paradigm that is administered in the homecage. Mice voluntarily self-administer oxycodone in this paradigm without any taste modification such as sweeteners, and exhibit preference for oxycodone, escalation of intake, physical signs of dependence, reinstatement of seeking after withdrawal, and a subset of animals demonstrate drug taking that is resistant to negative consequences. This model is therefore translationally relevant and can be useful for studying the neurobiological substrates specifically relevant to prescription opioid abuse.